JUSTIFICATIVA E OBJETIVOS:
o m i n a d o s p o r h e m a t o l o g i s ta s e p o r t o d o o c o r p o clínico-cirúrgico. Quando pacientes hemofílicos submetem-se a procedimentos cirúrgicos é necessário o envolvimento de
Dexmedetomidine is an innovative drug for sedation and analgesia. Its major qualities are fast onset and titration, allowing for changes in sedation and analgesia depth. In addition, it has a synergism with commonly used anesthetic drugs, with a low incidence of side effects and minor respiratory depression.
Diseases such as SAH and osteoarthritis are highly prevalent in obese patients. There were major postoperative respiratory system complications. This stresses the importance of the anesthetic technique and of postoperative analgesia allowing for early ambulation and the ability to normally breathe and cough. It has been observed that several aspects of anesthesia for obese patients are already defined as beneficial or noxious; however, several subjects are still undefined and should be discussed and studied to constantly improve the anesthetic management of such patients.
RESUMOEstivalet FF, Bagatini A, Gomes CR -Remifentanil Associado ao Propofol ou Sevoflurano para Colecistectomia Videolaparoscópica. Estudo Comparativo
Justificativa e Objetivos -Técnicas de anestesia venosa, i n a l a t ó r i a o u c o m b i n a d a s t ê m s i d o u t i l i z a d a s pa
Perioperative blood loss for all groups was high, with need for allogeneic blood transfusion. Virtually all patients have tolerated blood loss since in general they were young patients, physical status ASA I and II without associated diseases. Hematocrit has not returned to preoperative values after 14 days.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.